Sentence examples for upper body obesity from inspiring English sources

In the present study, the significant increase in waist and hip circumference in obese group in comparison to normal weight group and linear correlation between BMI and the waist and hip circumference in the obese group suggest that the women with increased upper body obesity are at an increased risk for breast cancer.

It is widely accepted that the influence of obesity on risk of breast cancer specifically applies to upper body obesity.

However, there are concerns that the BI method might underestimate upper body obesity [ 51], and dual energy X-ray absorptiometry might be more accurate for evaluating BF%.

The association of leptin to waist circumference (a surrogate for upper body obesity) and hip circumference confirms findings in Mexican American populations [ 49, 50].

Jean Vague, 6 a French investigator, defined two distinct morphologic obesity subtypes in women: android or upper body obesity, which was associated with insulin resistance, diabetes, and cardiovascular disease, and gynecoid or lower body obesity, which was not associated with these adverse outcomes.

The cut-off value of central obesity was considered high risk WHR= >0.80 or waist measurement >80% of hip measurement for women for females and >0.95 for males that is >95% for men indicates central (upper body) obesity and is considered high risk for diabetes & CVS disorders.

Additionally, meal fat storage is more efficient in peripheral vs. abdominal SAT of women with gluteal-femoral obesity; in upper body obese women or obese men there are no such regional differences [ 113].

FFA release is greater with upper-body obesity, which is associated with less suppression during a hyperinsulinemic clamp (39) or in the postprandial state (40).

There is a specific relationship with upper-body obesity, with higher waist/hip ratio an important independent positive predictor of flow-mediated dilatation [ 20] and arterial stiffness [ 21].

The associations seen in this study of trunk SAT change with metabolic parameters followed a pattern quite similar to that observed for VAT and thus are consistent with reports of greater metabolic risk with upper-body obesity.

Among the 324 subjects with upper-body obesity, metformin induced a significant weight loss (1 2 kg) with significant improvement of metabolic syndrome parameters after one year of treatment.